Suppr超能文献

多药耐药相关蛋白MGr1-Ag与人类37 kDa层粘连蛋白受体前体相同。

Multidrug-resistance-associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor.

作者信息

Shi Y, Zhai H, Wang X, Wu H, Ning X, Han Y, Zhang D, Xiao B, Wu K, Fan D

机构信息

Institute of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Shaanxi Province, PR China.

出版信息

Cell Mol Life Sci. 2002 Sep;59(9):1577-83. doi: 10.1007/s00018-002-8531-6.

Abstract

We report the isolation and functional characterization of the gene encoding MGr1-Ag, a multidrug-resistance-associated protein. A lambdagt11 cDNA library derived from colorectal carcinoma SW480 cells was screened with monoclonal antibody MGr1. DNA homology analysis of 22 positive clones (designated R1-R22) suggested human 37-kDa laminin receptor precursor (37LRP, R7/R9/R15/R16/R19/R20) and a novel gene (R22) as candidate genes encoding MGr1-Ag. Western blot analysis showed that anti-R20 serum reacted with a unique protein band that was consistent with MGr1-Ag, while anti-R22 serum could not react with MGr1-Ag. The coding gene for MGr1-Ag was amplified using reverse transcription-PCR. Sequence analysis revealed that the MGr1-Ag and 37LRP genes shared the same coding sequence. An in vitro drug sensitivity assay indicated that down-regulation of 37LRP by an antisense technique could significantly enhance the cytotoxicity of anticancer drugs to gastric cancer cells. Thus we draw the conclusion that MGr1-Ag is identical to 37LRP.

摘要

我们报告了编码MGr1-Ag(一种多药耐药相关蛋白)的基因的分离及功能特性。用单克隆抗体MGr1筛选源自结肠直肠癌SW480细胞的λgt11 cDNA文库。对22个阳性克隆(命名为R1-R22)的DNA同源性分析表明,人37-kDa层粘连蛋白受体前体(37LRP,R7/R9/R15/R16/R19/R20)和一个新基因(R22)是编码MGr1-Ag的候选基因。蛋白质免疫印迹分析显示,抗R20血清与一条与MGr1-Ag一致的独特蛋白带发生反应,而抗R22血清不能与MGr1-Ag发生反应。使用逆转录PCR扩增MGr1-Ag的编码基因。序列分析表明,MGr1-Ag和37LRP基因具有相同的编码序列。体外药敏试验表明,通过反义技术下调37LRP可显著增强抗癌药物对胃癌细胞的细胞毒性。因此我们得出结论,MGr1-Ag与37LRP相同。

相似文献

引用本文的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验